On October 24, 2017 Myriad Genetics, Inc. (NASDAQ: MYGN) reported that it will hold its fiscal first-quarter 2018 sales and earnings conference call with investors and analysts at 4:30 p.m. ET on Tuesday, November 7, 2017 (Press release, Myriad Genetics, OCT 24, 2017, View Source [SID1234521129]). During the call, Mark C. Capone, president and CEO and Bryan Riggsbee, CFO, will provide an overview of Myriad’s financial performance for the fiscal first-quarter and provide a business update.

To listen to the call, interested parties in the United States may dial 800-701-6414 or +1 303-223-4376 for international callers. All callers will be asked to reference reservation number 21859999. The conference call also will be available through a live webcast and a slide presentation pertaining to the earnings call will also be available under the investor section of our website at www.myriad.com. A replay of the call will be available two hours after the end of the call for seven days and may be accessed by dialing 800-633-8284 within the United States or +1 402-977-9140 for international callers and entering reservation number 21859999.